Position in LGND
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$36,136
+$9,289 QoQ
Shares Held
181
+27.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crewe Advisors LLC holds $1,045,793 across 17 Biotechnology names. LGND ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAUT |
Nautilus Biotechnology, Inc.
|
136,052 | $527,881 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
500 | $223,270 | |
| 3 | BNTX |
BioNTech SE
|
809 | $71,903 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
1,999 | $37,781 | |
| 5 | MRNA |
Moderna, Inc.
|
726 | $36,880 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
This page
|
181 | $36,136 | |
| 7 | ASBP |
Aspire Biopharma Holdings, Inc.
|
20,335 | $20,945 | |
| 8 | MNKD |
Mannkind Corp
|
8,074 | $19,781 |
All Filings in LGND
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,136 | 181 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $26,847 | 142 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $23,559 | 133 | Shares | Sole | 2025-11-13 | |
| 2024-06-30 | $17,441 | 207 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||